Adcetris 51144-0050
Generic: Brentuximab Vedotin
Product NDC
51144-0050- Manufacturer
- Seagen Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 25, 2011
- Listing Expires
- December 31, 2026
- Application
- BLA125388
Need to source Adcetris? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brentuximab Vedotin | 50 mg/10.5mL |
Drug Class
CD30-directed Immunoconjugate [EPC]CD30-directed Antibody Interactions [MoA]CD30-directed Immunoconjugate [EPC]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01) / 10.5 mL in 1 VIAL, SINGLE-DOSE